Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-β-cyclodextrin, (SBE)7M-β-CD, as a solubilizing and osmotic agent

Journal of Pharmaceutical Sciences

Volumn 96, Issue 9, 2007, Pages 2364-2374

  Sotthivirat, Sutthilug ^a,b   Haslam, John L ^a   Stella, Valentino J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Controlled release; Pellet; Prednisolone; Sulfobutylether cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; LACTOSE; OSMOTIC AGENT; PREDNISOLONE; SOLUBILIZER;

ARTICLE; CHEMICAL STRUCTURE; COMPARATIVE STUDY; CONTROLLED RELEASE FORMULATION; DRUG FORMULATION; DRUG RELEASE; FREEZE DRYING; MEMBRANE; OSMOTIC PRESSURE; OSMOTIC PUMP; PELLET EXTRUSION; POROSITY; SOLUBILITY; WATER CONTENT;

EID: 34748841656     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20891     Document Type: Article

References (34)

1. Stella VJ, Rajewski RA. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14:556-567.
2. Thompson DO. 1997. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14:1-104.
3. Rajewski RA, Stella VJ. 1996. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142-1169.
4. Irie T, Uekama K. 1997. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147-162.
5. 7m-β-CD. Pharm Res 15:1562-1568.
6. 7m-β-CD. Pharm Res 16:549-554.
7. 7m-β-CD as both a solubilizer and osmotic agent. J Control Release 60:311-319.
8. 7m-β-cyclodextrin as both a solubilizing and an osmotic pump agent. J Control Release 58:29-38.
9. 7m-β-cyclodextrin as a solubilizing agent. J Pharm Sci 90:807-816.
10. Stella VJ, Rao VM, Zannou EA. 2002. The pharmaceutical use of captisol: Some surprising observa-tions. J Incl Phenom Macro 44:29-33.
11. Zannou EA, Streng WH, Stella VJ. 2001. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins. Pharm Res 18:1226-1231.
12. Rao VM, Stella VJ. 2003. When can cyclodextrins be considered for solubilization purposes? J Pharm Sci 92:927-932.
13. 7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). Int J Pharm 286:81-88.
14. Ghebre-Sellassie I. 1989. Pharmaceutical pelletization technology. 1st edition. New York: Mercel Dekker.
15. Ghebre-Sellassie I. 1994. Multiparticulate oral drug delivery. 1st edition. New York: Mercel Dekker.
16. Bechgaard H, Nielsen GH. 1978. Controlled-release multiple-units and single-unit doses. A literature review. Drug Dev Ind Pharm 4:53-67.
17. Zentner GM, McClelland GA, Sutton SC. 1991. Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Control Release 16:237-243.
18. Zentner GM, Rork GS, Himmelstein KJ. 1985. The controlled porosity osmotic pump. J Control Release 1:269-282.
19. Zentner GM, Rork GS, Himmelstein KJ. 1985. Osmotic flow through controlled porosity films: An approach to delivery of water soluble compounds. J Control Release 2:217-229.
20. Theeuwes F. 1975. Elementary osmotic pump. J Pharm Sci 64:1987-1991.
21. Sotthivirat S. 2005. The use of sulfobutyl ether-beta-cyclodextrin in controlled delivery dosage forms. Lawrence, KS: University of Kansas. 256 p.
22. 7M-β-CD. Int J Pharmac 330:73-81.
23. Zannou EA. 2000. A mechanistic study of drug release from cyclodextrin-based controlled porosity osmotic pump tablets. Lawrence, KS: University of Kansas, 243 p.
24. Catena GC, Bright FV. 1989. Thermodynamic study on the effects of β-cyclodextrin inclusion with anilinonaphthalenesulfonates. Anal Chem 61:905-909.
25. Sotthivirat S, Lubach JW, Haslam JL, Munson EJ, Stella VJ. Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy. J Pharm Sci (in press).
26. Appel LE, Zentner GM. 1991. Use of modified ethyl cellulose latexes for microporous coating of osmotic tablets. Pharm Res 8:600-604.
27. Ozturk AG, Ozturk SS, Palsson BO, Wheatley TA, Dressman JB. 1990. Mechanism of release from pellets coated with an ethyl cellulose-based film. J Control Release 14:203-213.
28. Gale R, Chandrasekaran SK, Swanson D, Wright J. 1980. Use of osmotically active therapeutic agents in monolithic systems. J Membr Sci 7:319-331.
29. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. 1995. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release 35:127-136.
30. Ragnarsson G, Sandberg A, Johansson MO, Lindstedt B, Sjoegren J. 1992. In vitro release characteristics of a membrane-coated pellet formulation. Influence of drug solubility and particle size. Int J Pharm 79:223-232.
31. Wright J, Chandrasekaran SK, Gale R, Swanson D. 1981. A model for the release of osmotically active agents from monolithic polymeric matrixes. AIChE Symp Ser 77:62-68.
32. Zhang Y, Zhang Z, Wu F. 2003. A novel pulsed-release system based on swelling and osmotic pumping mechanism. J Control Release 89:47-55.
33. Theeuwes F. 1983. Evolution and design of 'rate controlled' osmotic forms. Curr Med Res Opin 8:20-27.
34. Verma RK, Mishra B, Garg S. 2000. Osmotically controlled oral drug delivery. Drug Dev Ind Pharm 26:695-708.